Chemoinformaics analysis of 9,12-Octadecadienal
| Molecular Weight | 264.453 | nRot | 14 |
| Heavy Atom Molecular Weight | 232.197 | nRig | 3 |
| Exact Molecular Weight | 264.245 | nRing | 0 |
| Solubility: LogS | -5.897 | nHRing | 0 |
| Solubility: LogP | 6.622 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 52.1994 |
| nHD | 0 | BPOL | 32.9706 |
| QED | 0.214 |
| Synth | 2.505 |
| Natural Product Likeliness | 1.379 |
| NR-PPAR-gamma | 0.783 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.014 |
| HIA | 0.006 |
| CACO-2 | -4.631 |
| MDCK | 0.0000131 |
| BBB | 0.943 |
| PPB | 0.956854 |
| VDSS | 3.334 |
| FU | 0.0240313 |
| CYP1A2-inh | 0.711 |
| CYP1A2-sub | 0.176 |
| CYP2c19-inh | 0.468 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.391 |
| CYP2c9-sub | 0.94 |
| CYP2d6-inh | 0.358 |
| CYP2d6-sub | 0.237 |
| CYP3a4-inh | 0.519 |
| CYP3a4-sub | 0.044 |
| CL | 5.622 |
| T12 | 0.184 |
| hERG | 0.078 |
| Ames | 0.231 |
| ROA | 0.005 |
| SkinSen | 0.987 |
| Carcinogencity | 0.297 |
| EI | 0.971 |
| Respiratory | 0.942 |
| NR-Aromatase | 0.622 |
| Antiviral | Yes |
| Prediction | 0.626338 |